Explaining the social gradient in coronary heart disease: comparing relative and absolute risk approaches.

Journal of Epidemiology and Community Health
J W LynchKathleen Bainbridge

Abstract

There are contradictory perspectives on the importance of conventional coronary heart disease (CHD) risk factors in explaining population levels and social gradients in CHD. This study examined the contribution of conventional CHD risk factors (smoking, hypertension, dyslipidaemia, and diabetes) to explaining population levels and to absolute and relative social inequalities in CHD. This was investigated in an entire population and by creating a low risk sub-population with no smoking, dyslipidaemia, diabetes, and hypertension to simulate what would happen to relative and social inequalities in CHD if conventional risk factors were removed. Population based study of 2682 eastern Finnish men aged 42, 48, 54, 60 at baseline with 10.5 years average follow up of fatal (ICD9 codes 410-414) and non-fatal (MONICA criteria) CHD events. In the whole population, 94.6% of events occurred among men exposed to at least one conventional risk factor, with a PAR of 68%. Adjustment for conventional risk factors reduced relative social inequality by 24%. However, in a low risk population free from conventional risk factors, absolute social inequality reduced by 72%. Conventional risk factors explain the majority of absolute social inequality in ...Continue Reading

References

Dec 1, 1990·Journal of Epidemiology and Community Health·G D SmithG Rose
Jan 6, 1989·JAMA : the Journal of the American Medical Association·M C FioreR M Davis
Mar 1, 1985·International Journal of Epidemiology·G Rose
Jan 1, 1981·British Heart Journal·G Rose, M G Marmot
Oct 1, 1995·Circulation·J LynchJ T Salonen
Jan 8, 1994·BMJ : British Medical Journal·G D Smith, M Egger
Jun 23, 1993·JAMA : the Journal of the American Medical Association·N E AdlerS L Syme
Mar 1, 1997·Social Science & Medicine·S Macintyre
Jul 26, 1997·Lancet·S L Syme, J L Balfour
Jan 15, 1998·The New England Journal of Medicine·B S McEwen
May 16, 1998·American Journal of Public Health·B RockhillC Weinberg
Jun 12, 1998·JAMA : the Journal of the American Medical Association·P M LantzJ Chen
Mar 27, 2001·American Journal of Health Promotion : AJHP·B D SmedleyUNKNOWN Committee on Capitalizing on Social Science and Behavioral Research to Improve the Public's Health
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
May 23, 2001·International Journal of Epidemiology·S Ebrahim, G D Smith
Jan 5, 2002·International Journal of Epidemiology·A EvansUNKNOWN WHO MONICA Project
Jan 24, 2003·International Journal of Epidemiology·Robert Beaglehole, Paul Magnus
Aug 21, 2003·JAMA : the Journal of the American Medical Association·Philip GreenlandPeter W Wilson
Apr 15, 2004·International Journal of Epidemiology·Jonathan R EmbersonMary Walker
Apr 15, 2004·International Journal of Epidemiology·Michael Marmot
Jun 23, 2004·Lancet·Robert BeagleholeMartin McKee
Aug 21, 2004·International Journal of Epidemiology·J R EmbersonM Walker
Jan 11, 2005·Lancet·Peter WhincupA G Shaper
Mar 12, 2005·Annual Review of Public Health·John Lynch, George Davey Smith
Sep 10, 2005·American Journal of Epidemiology·Tiina LaatikainenSimon Capewell

❮ Previous
Next ❯

Citations

Aug 4, 2010·International Journal of Public Health·Bruna Galobardes
Apr 17, 2013·European Journal of Clinical Pharmacology·Helle Wallach-KildemoesTheis Lange
Oct 24, 2006·Lancet·Mauricio Avendano
Sep 23, 2009·Nature Reviews. Cardiology·Alexander M ClarkAndy Wielgosz
Jul 27, 2011·Nature Reviews. Cardiology·Alexander M ClarkDavid R Thompson
Feb 26, 2010·Biodemography and Social Biology·Noreen Goldman, Jennifer B Dowd
Feb 5, 2013·European Heart Journal·Robby NieuwlaatSalim Yusuf
Nov 13, 2010·European Journal of Public Health·Giovanni VeronesiGiancarlo Cesana
Oct 13, 2012·Health Policy and Planning·Nicholas B KingMeredith E Young
May 6, 2008·International Journal of Epidemiology·Jennifer Beam Dowd, Allison E Aiello
Dec 26, 2008·International Journal of Epidemiology·Amanda M SimanekAllison E Aiello
Apr 21, 2009·International Journal of Epidemiology·F Javier Nieto
Nov 6, 2009·International Journal of Epidemiology·Lindsay McLarenSharon Kirkpatrick
Oct 16, 2012·International Journal of Epidemiology·Oyvind NæssLaust H Mortensen
Jan 17, 2013·Journal of Epidemiology and Community Health·Laura D HoweCarol Propper
Oct 14, 2009·Journal of Epidemiology and Community Health·David H RehkopfLuis Rosero-Bixby
Feb 25, 2009·International Journal for Equity in Health·Adolfo Martinez Valle
Feb 23, 2008·Emerging Themes in Epidemiology·James Woodcock, Rachel Aldred
Dec 8, 2007·Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi·Young-Ho Khang
Apr 9, 2013·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Marc Marí-Dell'olmoMaica Rodríguez-Sanz
Jan 12, 2011·Annual Review of Public Health·Sam HarperGeorge Davey Smith
Aug 16, 2013·Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi·Young-Ho Khang
Feb 16, 2013·Lancet·Mariachiara Di CesareUNKNOWN Lancet NCD Action Group
Jan 10, 2012·Annals of Epidemiology·Aino LammintaustaUNKNOWN FINAMI Study Group
Sep 17, 2015·Medicine·Mortada H El-ShabrawiMichael Krawinkel
Mar 19, 2014·International Journal of Epidemiology·Seungmi YangMichael S Kramer
Aug 19, 2007·Social Science & Medicine·Ellen Van de PoelEddy Van Doorslaer
Apr 10, 2010·The Milbank Quarterly·Sam HarperJohn Lynch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.